Search dm+d | This VMP cannot be matched against our prescribing data.
| Name | Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials |
| BNF code | 0601012F0AAAEAE |
| Virtual Therapeutic Moiety | Insulin lispro biphasic |
| Abbreviated name | Insulin lispro biphasic 25/75 100units/ml inj 10ml vials |
| Basis of preferred name | Other |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 10.000 |
| Unit dose form units | ml |
| Unit dose unit of measure | vial |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Insulin lispro |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 25.000 |
| Strength value numerator unit | unit |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Virtual Product Ingredient | |
| Ingredient | Insulin lispro protamine |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 412210000 |
| Strength value numerator | 75.000 |
| Strength value numerator unit | unit |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | suspensioninjection.subcutaneous |
| Dose Form | |
| Formulation | Suspension for injection |
| Drug Route | |
| Route | Subcutaneous |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Humalog Mix25 100units/ml suspension for injection 10ml vials (Eli Lilly and Company Ltd) | |
| Virtual Medicinal Product Packs | |
| Insulin lispro biphasic 25/75 100units/ml suspension for injection 10ml vials 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.